1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathy Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Sickle cell disease 1.2.3 Alpha thalassemia 1.2.4 Beta thalassemia 1.3 Market by Application 1.3.1 Global Hemoglobinopathy Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Diagnostic laboratories 1.3.4 Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemoglobinopathy Market Perspective (2015-2026) 2.2 Global Hemoglobinopathy Growth Trends by Regions 2.2.1 Hemoglobinopathy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Hemoglobinopathy Historic Market Share by Regions (2015-2020) 2.2.3 Hemoglobinopathy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemoglobinopathy Players by Market Size 3.1.1 Global Top Hemoglobinopathy Players by Revenue (2015-2020) 3.1.2 Global Hemoglobinopathy Revenue Market Share by Players (2015-2020) 3.2 Global Hemoglobinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hemoglobinopathy Revenue 3.4 Global Hemoglobinopathy Market Concentration Ratio 3.4.1 Global Hemoglobinopathy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Revenue in 2019 3.5 Key Players Hemoglobinopathy Area Served 3.6 Key Players Hemoglobinopathy Product Solution and Service 3.7 Date of Enter into Hemoglobinopathy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemoglobinopathy Breakdown Data by Type (2015-2026) 4.1 Global Hemoglobinopathy Historic Market Size by Type (2015-2020) 4.2 Global Hemoglobinopathy Forecasted Market Size by Type (2021-2026) 5 Hemoglobinopathy Breakdown Data by Application (2015-2026) 5.1 Global Hemoglobinopathy Historic Market Size by Application (2015-2020) 5.2 Global Hemoglobinopathy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Hemoglobinopathy Market Size (2015-2026) 6.2 North America Hemoglobinopathy Market Size by Type (2015-2020) 6.3 North America Hemoglobinopathy Market Size by Application (2015-2020) 6.4 North America Hemoglobinopathy Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Hemoglobinopathy Market Size (2015-2026) 7.2 Europe Hemoglobinopathy Market Size by Type (2015-2020) 7.3 Europe Hemoglobinopathy Market Size by Application (2015-2020) 7.4 Europe Hemoglobinopathy Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Hemoglobinopathy Market Size (2015-2026) 8.2 China Hemoglobinopathy Market Size by Type (2015-2020) 8.3 China Hemoglobinopathy Market Size by Application (2015-2020) 8.4 China Hemoglobinopathy Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Hemoglobinopathy Market Size (2015-2026) 9.2 Japan Hemoglobinopathy Market Size by Type (2015-2020) 9.3 Japan Hemoglobinopathy Market Size by Application (2015-2020) 9.4 Japan Hemoglobinopathy Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Hemoglobinopathy Market Size (2015-2026) 10.2 Southeast Asia Hemoglobinopathy Market Size by Type (2015-2020) 10.3 Southeast Asia Hemoglobinopathy Market Size by Application (2015-2020) 10.4 Southeast Asia Hemoglobinopathy Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Abbott Diagnostics 11.1.1 Abbott Diagnostics Company Details 11.1.2 Abbott Diagnostics Business Overview 11.1.3 Abbott Diagnostics Hemoglobinopathy Introduction 11.1.4 Abbott Diagnostics Revenue in Hemoglobinopathy Business (2015-2020)) 11.1.5 Abbott Diagnostics Recent Development 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Details 11.2.2 Bio-Rad Laboratories Business Overview 11.2.3 Bio-Rad Laboratories Hemoglobinopathy Introduction 11.2.4 Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2015-2020) 11.2.5 Bio-Rad Laboratories Recent Development 11.3 Danaher Corporation 11.3.1 Danaher Corporation Company Details 11.3.2 Danaher Corporation Business Overview 11.3.3 Danaher Corporation Hemoglobinopathy Introduction 11.3.4 Danaher Corporation Revenue in Hemoglobinopathy Business (2015-2020) 11.3.5 Danaher Corporation Recent Development 11.4 Mindray Medical International 11.4.1 Mindray Medical International Company Details 11.4.2 Mindray Medical International Business Overview 11.4.3 Mindray Medical International Hemoglobinopathy Introduction 11.4.4 Mindray Medical International Revenue in Hemoglobinopathy Business (2015-2020) 11.4.5 Mindray Medical International Recent Development 11.5 Nexcelom Bioscience 11.5.1 Nexcelom Bioscience Company Details 11.5.2 Nexcelom Bioscience Business Overview 11.5.3 Nexcelom Bioscience Hemoglobinopathy Introduction 11.5.4 Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2015-2020) 11.5.5 Nexcelom Bioscience Recent Development 11.6 Nihon Kohden 11.6.1 Nihon Kohden Company Details 11.6.2 Nihon Kohden Business Overview 11.6.3 Nihon Kohden Hemoglobinopathy Introduction 11.6.4 Nihon Kohden Revenue in Hemoglobinopathy Business (2015-2020) 11.6.5 Nihon Kohden Recent Development 11.7 PerkinElmer 11.7.1 PerkinElmer Company Details 11.7.2 PerkinElmer Business Overview 11.7.3 PerkinElmer Hemoglobinopathy Introduction 11.7.4 PerkinElmer Revenue in Hemoglobinopathy Business (2015-2020) 11.7.5 PerkinElmer Recent Development 11.8 Siemens Healthineers 11.8.1 Siemens Healthineers Company Details 11.8.2 Siemens Healthineers Business Overview 11.8.3 Siemens Healthineers Hemoglobinopathy Introduction 11.8.4 Siemens Healthineers Revenue in Hemoglobinopathy Business (2015-2020) 11.8.5 Siemens Healthineers Recent Development 11.9 Sysmex Corporation 11.9.1 Sysmex Corporation Company Details 11.9.2 Sysmex Corporation Business Overview 11.9.3 Sysmex Corporation Hemoglobinopathy Introduction 11.9.4 Sysmex Corporation Revenue in Hemoglobinopathy Business (2015-2020) 11.9.5 Sysmex Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemoglobinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Sickle cell disease Table 4. Key Players of Alpha thalassemia Table 5. Key Players of Beta thalassemia Table 6. Global Hemoglobinopathy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 7. Global Hemoglobinopathy Market Size by Regions (US$ Million): 2020 VS 2026 Table 8. Global Hemoglobinopathy Market Size by Regions (2015-2020) (US$ Million) Table 9. Global Hemoglobinopathy Market Share by Regions (2015-2020) Table 10. Global Hemoglobinopathy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 11. Global Hemoglobinopathy Market Share by Regions (2021-2026) Table 12. Hemoglobinopathy Market Market Trends Table 13. Hemoglobinopathy Market Drivers Table 14. Hemoglobinopathy Market Challenges Table 15. Hemoglobinopathy Market Restraints Table 16. Global Hemoglobinopathy Revenue by Players (2015-2020) (US$ Million) Table 17. Global Hemoglobinopathy Market Share by Players (2015-2020) Table 18. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019) Table 19. Global Hemoglobinopathy by Players Market Concentration Ratio (CR5 and HHI) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hemoglobinopathy Product Solution and Service Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 24. Global Hemoglobinopathy Market Size Share by Type (2015-2020) Table 25. Global Hemoglobinopathy Revenue Market Share by Type (2021-2026) Table 26. Global Hemoglobinopathy Market Size Share by Application (2015-2020) Table 27. Global Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 28. Global Hemoglobinopathy Market Size Share by Application (2021-2026) Table 29. North America Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 30. North America Hemoglobinopathy Market Share by Type (2015-2020) Table 31. North America Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 32. North America Hemoglobinopathy Market Share by Application (2015-2020) Table 33. North America Hemoglobinopathy Market Size by Country (US$ Million) (2015-2020) Table 34. North America Hemoglobinopathy Market Share by Country (2015-2020) Table 35. Europe Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 36. Europe Hemoglobinopathy Market Share by Type (2015-2020) Table 37. Europe Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 38. Europe Hemoglobinopathy Market Share by Application (2015-2020) Table 39. Europe Hemoglobinopathy Market Size by Country (US$ Million) (2015-2020) Table 40. Europe Hemoglobinopathy Market Share by Country (2015-2020) Table 41. China Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 42. China Hemoglobinopathy Market Share by Type (2015-2020) Table 43. China Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 44. China Hemoglobinopathy Market Share by Application (2015-2020) Table 45. China Hemoglobinopathy Market Size by Region (US$ Million) (2015-2020) Table 46. China Hemoglobinopathy Market Share by Region (2015-2020) Table 47. Japan Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 48. Japan Hemoglobinopathy Market Share by Type (2015-2020) Table 49. Japan Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 50. Japan Hemoglobinopathy Market Share by Application (2015-2020) Table 51. Japan Hemoglobinopathy Market Size by Country (US$ Million) (2015-2020) Table 52. Japan Hemoglobinopathy Market Share by Country (2015-2020) Table 53. Southeast Asia Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 54. Southeast Asia Hemoglobinopathy Market Share by Type (2015-2020) Table 55. Southeast Asia Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 56. Southeast Asia Hemoglobinopathy Market Share by Application (2015-2020) Table 57. Southeast Asia Hemoglobinopathy Market Size by Country (US$ Million) (2015-2020) Table 58. Southeast Asia Hemoglobinopathy Market Share by Country (2015-2020) Table 59. Abbott Diagnostics Company Details Table 60. Abbott Diagnostics Business Overview Table 61. Abbott Diagnostics Product Table 62. Abbott Diagnostics Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 63. Abbott Diagnostics Recent Development Table 64. Bio-Rad Laboratories Company Details Table 65. Bio-Rad Laboratories Business Overview Table 66. Bio-Rad Laboratories Product Table 67. Bio-Rad Laboratories Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 68. Bio-Rad Laboratories Recent Development Table 69. Danaher Corporation Company Details Table 70. Danaher Corporation Business Overview Table 71. Danaher Corporation Product Table 72. Danaher Corporation Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 73. Danaher Corporation Recent Development Table 74. Mindray Medical International Company Details Table 75. Mindray Medical International Business Overview Table 76. Mindray Medical International Product Table 77. Mindray Medical International Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 78. Mindray Medical International Recent Development Table 79. Nexcelom Bioscience Company Details Table 80. Nexcelom Bioscience Business Overview Table 81. Nexcelom Bioscience Product Table 82. Nexcelom Bioscience Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 83. Nexcelom Bioscience Recent Development Table 84. Nihon Kohden Company Details Table 85. Nihon Kohden Business Overview Table 86. Nihon Kohden Product Table 87. Nihon Kohden Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 88. Nihon Kohden Recent Development Table 89. PerkinElmer Company Details Table 90. PerkinElmer Business Overview Table 91. PerkinElmer Product Table 92. PerkinElmer Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 93. PerkinElmer Recent Development Table 94. Siemens Healthineers Business Overview Table 95. Siemens Healthineers Product Table 96. Siemens Healthineers Company Details Table 97. Siemens Healthineers Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 98. Siemens Healthineers Recent Development Table 99. Sysmex Corporation Company Details Table 100. Sysmex Corporation Business Overview Table 101. Sysmex Corporation Product Table 102. Sysmex Corporation Revenue in Hemoglobinopathy Business (2015-2020) (US$ Million) Table 103. Sysmex Corporation Recent Development Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathy Market Share by Type: 2020 VS 2026 Figure 2. Sickle cell disease Features Figure 3. Alpha thalassemia Features Figure 4. Beta thalassemia Features Figure 5. Global Hemoglobinopathy Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Diagnostic laboratories Case Studies Figure 8. Clinics Case Studies Figure 9. Hemoglobinopathy Report Years Considered Figure 10. Global Hemoglobinopathy Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Hemoglobinopathy Market Share by Regions: 2020 VS 2026 Figure 12. Global Hemoglobinopathy Market Share by Regions (2021-2026) Figure 13. Global Hemoglobinopathy Market Share by Players in 2019 Figure 14. Global Top Hemoglobinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Hemoglobinopathy Revenue in 2019 Figure 16. North America Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Abbott Diagnostics Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 44. Bio-Rad Laboratories Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 45. Danaher Corporation Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 46. Mindray Medical International Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 47. Nexcelom Bioscience Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 48. Nihon Kohden Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 49. PerkinElmer Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 50. Siemens Healthineers Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 51. Sysmex Corporation Revenue Growth Rate in Hemoglobinopathy Business (2015-2020) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Abbott Diagnostics Bio-Rad Laboratories Danaher Corporation Mindray Medical International Nexcelom Bioscience Nihon Kohden PerkinElmer Siemens Healthineers Sysmex Corporation